Melanotan II Injectable Recalled for Manufacturing Sterility Defect
Melanotan II injection (35 vials) is being recalled nationwide due to manufacturing deviations that could compromise product sterility. Patients should not use affected lots and should contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a risk-of-harm sterile injectable drug with manufacturing deviations that could compromise sterility. No illnesses have been reported, meeting the criteria for High severity per the rubric.
Plain-English summary
Melanotan II 1 mg/mL injectable medication has been recalled by the U.S. Food and Drug Administration. The recall involves 35 vials manufactured by North American Custom Laboratories, LLC (operating as FarmaKeio Superior Custom Compounding) and distributed nationwide. The affected lot numbers are 32610 (use-by date: 4/4/2022) and 35126 (use-by date: 6/7/2022).
The recall was initiated due to deviations from Current Good Manufacturing Practices (CGMP) that undermine confidence in the sterility of the product. As Melanotan II is an injectable medication intended for sterile administration, these manufacturing defects create a potential safety concern.
Patients or healthcare providers who have this medication should not use the affected lot numbers. Contact your healthcare provider or the FDA if you have questions about whether you have received this recalled product.
The recalled product
- Product
- Melanotan II 1 mg/mL (10 mL) Injection, 10mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA
- Category
- Drug
- Affected units
- 35
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 32610 BUD: 4/4/2022
- 35126 BUD: 6/7/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
See all →- HighIpamorelin and Sermorelin Injectable Medications Recalled Due to Sterility Deviations
FDA (Drugs) · 2022-04-27
- HighSermorelin Acetate Injection Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2022-04-27
- HighInjectable Drug Recalled for Sterility Concerns Due to Manufacturing Defects
FDA (Drugs) · 2022-04-27
- HighInjectable Drug Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-04-27
- HighPT-141 Injection Recalled for Sterility Assurance Defect
FDA (Drugs) · 2022-04-27
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24